Tech For Longevity
ACCUEIL
REPLAYS
DEMOZONE
INTERVENANTS
À PROPOS
en
fr
Participer à la session
🇫🇷 Sang, biomarqueurs et avancées: Révolutionner la longévité grâce à la détection précoce des cancers multiples
20 nov. 2024
—
19:23 CET
-
19:38 CET
Présentée par
DMM
Dr Michel
Mouly
Chirurgien gynécologue, obstétricien...
PPPB
Prof Patrizia
Paterlini Brechot
Rarecells
Founder and President at Rarecells,...
DVL
Dr Valérie
Leduc
Maison Epigenetic
Co-founder of Maison Epigenetic and...
Présentée
par
DVL
Dr Valérie
Leduc
Co-founder of Maison Epigenetic and Medical Doctor
DMM
Dr Michel
Mouly
Chirurgien gynécologue, obstétricien et cancérologue
PPPB
Prof Patrizia
Paterlini Brechot
Founder and President at Rarecells, Professor at Université de Paris
Sessions
recommandées
20 nov.
15:00
-
15:10
🇬🇧 Opening Tech for Longevity
HO
Henri-Nicolas
OLIVIER
Maison Epigenetic
Co-Founder & CEO
DG
Damien
Gromier
AI for Health by Artefact
CEO of Artefact Open Innovation & Founder of AI for Health
20 nov.
15:10
-
15:25
🇬🇧 The longevity investment landscape
PN
Phil
Newman
Longevity.Technology
CEO & Founder
20 nov.
15:25
-
15:45
🇬🇧 The $600 Billion Longevity Boom: Unlocking Investment Opportunities in the Age of Aging
MS
Montse
Suarez
IRIS Ventures
Founder & Managing Partner
AL
Arnaud
Laurent
OVNI Capital
Founding partner
AP
Anaïs
Pons
Eurazeo Brands
Principal
HO
Henri-Nicolas
OLIVIER
Maison Epigenetic
Co-Founder & CEO
20 nov.
15:45
-
15:59
🇬🇧 From AI to Longevity: Investing in the Future of Human Potential
HO
Henri-Nicolas
OLIVIER
Maison Epigenetic
Co-Founder & CEO
CB
Charles-Edouard
BOUEE
Adagia Partners
Co-Founder and Managing Partner